Immunostimulatory DNA--Dynavax. AIC, Amb a 1 immunostimulatory conjugate, HBV-ISS, ISS 1018, ISS DNA, ISS DNA--dynavax, ISS1, ISS2
- PMID: 12099166
- DOI: 10.2165/00126839-200203030-00011
Immunostimulatory DNA--Dynavax. AIC, Amb a 1 immunostimulatory conjugate, HBV-ISS, ISS 1018, ISS DNA, ISS DNA--dynavax, ISS1, ISS2
Similar articles
-
Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma.J Allergy Clin Immunol. 2002 Mar;109(3):455-62. doi: 10.1067/mai.2002.122156. J Allergy Clin Immunol. 2002. PMID: 11897991
-
AIC. Dynavax.Curr Opin Investig Drugs. 2003 May;4(5):603-7. Curr Opin Investig Drugs. 2003. PMID: 12833657 Review.
-
Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy.J Allergy Clin Immunol. 2001 Aug;108(2):191-7. doi: 10.1067/mai.2001.116984. J Allergy Clin Immunol. 2001. PMID: 11496233
-
HBV-ISS (Dynavax).Curr Opin Mol Ther. 2006 Apr;8(2):150-5. Curr Opin Mol Ther. 2006. PMID: 16610768
-
Progress in the development of new methods of immunotherapy: potential application of immunostimulatory DNA-conjugated to allergens for treatment of allergic respiratory conditions.Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2003;(94):304-12; discussion 312-3. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2003. PMID: 15119051 Review.
Cited by
-
Trial Watch: Experimental Toll-like receptor agonists for cancer therapy.Oncoimmunology. 2012 Aug 1;1(5):699-716. doi: 10.4161/onci.20696. Oncoimmunology. 2012. PMID: 22934262 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources